ArticleACS pharmacology & translational science2024

Novel Peptide DR3penA as a Low-Toxicity Antirenal Fibrosis Agent by Suppressing the TGF-β1/miR-212-5p/Low-Density Lipoprotein Receptor Class a Domain Containing 4/Smad Axis.

Bochuan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.